Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APPSwe/PS1ΔE9 Transgenic Female Mice

Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APPSwe/PS1ΔE9 Transgenic Female Mice

Alzheimer’s disease (AD) is a neurodegenerative disease that causes behavioral and cognitive impairments. The phytocannabinoid cannabidiol (CBD) has anti-inflammatory, antioxidant, and neuroprotective properties, and in vitro and limited in vivo evidence suggests that CBD possesses therapeutic-like...

Full description

Bibliographic Details
Main Authors:	Madilyn Coles, Georgia Watt, Fabian Kreilaus, Tim Karl
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Pharmacology
Subjects:	Alzheimer’s disease APPSwe/PS1ΔE9 transgenic mouse model cannabidiol treatment behavior
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.587604/full

Similar Items

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
by: Monica Garcia-Alloza, et al.
Published: (2006-12-01)

Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice
by: Se Jong Oh, et al.
Published: (2022-08-01)

Corrigendum: Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice
by: Se Jong Oh, et al.
Published: (2022-10-01)

THERAPEUTIC POTENTIAL OF A COMBINED CANNABIDIOL (CBD) - DELTA-9-TETRAHYDROCANNABINOL (THC) TREATMENT STRATEGY FOR APPSWE/PS1ΔE9 TRANSGENIC MICE
by: Madilyn Coles, et al.
Published: (2023-10-01)

Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
by: Miren Ettcheto, et al.
Published: (2021-07-01)

Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
by: Miren Ettcheto, et al.
Published: (2017-10-01)

Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice
by: Chouliaras Leonidas, et al.
Published: (2018-12-01)

EK100 and Antrodin C Improve Brain Amyloid Pathology in APP/PS1 Transgenic Mice by Promoting Microglial and Perivascular Clearance Pathways
by: Huey-Jen Tsay, et al.
Published: (2021-09-01)

Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
by: Qianru Rao, et al.
Published: (2022-11-01)

Altered membrane properties but unchanged intrinsic excitability and spontaneous postsynaptic currents in an aged APPswe/PS1dE9 model of Alzheimer’s disease
by: Shane M. Ohline, et al.
Published: (2022-08-01)

Cholinergic forebrain degeneration in the APPswe/PS1ΔE9 transgenic mouse
by: Sylvia E. Perez, et al.
Published: (2007-10-01)

Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice
by: Luisa Müller, et al.
Published: (2021-03-01)

Optimal condition of cannabis maceration to obtain the high cannabidiol and Δ9-tetrahydrocannabinol content
by: CHAOWALIT MONTON, et al.
Published: (2019-10-01)

Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain
by: Xiangpei Yue, et al.
Published: (2021-11-01)

Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice
by: Prakash Nidadavolu, et al.
Published: (2021-08-01)

The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia
by: Gabriela Visini, et al.
Published: (2022-11-01)

Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer’s-like mice
by: Helen Crehan, et al.
Published: (2020-01-01)

Anticancer properties of cannabidiol and Δ9-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines
by: Erin G. Whynot, et al.
Published: (2023-03-01)

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling
by: Lei Li, et al.
Published: (2020-02-01)

Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer's disease
by: Sha Liu, et al.
Published: (2016-09-01)

Cure-All cannabidiol? The cannabidiol content of commercial products
by: Michaela Mouton, et al.
Published: (2024-02-01)

YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2
by: Zheng-Yi Li, et al.
Published: (2017-04-01)

Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
by: Barkha J. Yadav-Samudrala, et al.
Published: (2024-03-01)

Comparative Study of Δ9-Tetrahydrocannabinol and Cannabidiol on Melanogenesis in Human Epidermal Melanocytes from Different Pigmentation Phototypes: A Pilot Study
by: Shilpi Goenka
Published: (2022-06-01)

Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer’s disease mouse models
by: Khaled S. Abd-Elrahman, et al.
Published: (2018-04-01)

Beneficial effects of cannabidiol from Cannabis
by: Sullim Lee, et al.
Published: (2024-03-01)

Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
by: Francesco Bartoli, et al.
Published: (2021-03-01)

Gastrodin as a multi-target protective compound reverses learning memory deficits and AD-like pathology in APP/PS1 transgenic mice
by: Yue-Qin Zeng, et al.
Published: (2021-02-01)

Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol
by: Černe Katarina
Published: (2020-03-01)

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
by: Madilyn Coles, et al.
Published: (2022-09-01)

Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
by: Joseph J. Wakshlag, et al.
Published: (2020-09-01)

Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001–2015
by: Albert Stuart Reece, et al.
Published: (2022-01-01)

Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice
by: Fiona Grueninger, et al.
Published: (2010-02-01)

YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice
by: Xiaowan Wang, et al.
Published: (2017-05-01)

The Combination of Δ<sup>9</sup>-Tetrahydrocannabinol and Cannabidiol Suppresses Mitochondrial Respiration of Human Glioblastoma Cells via Downregulation of Specific Respiratory Chain Proteins
by: Anne Rupprecht, et al.
Published: (2022-06-01)

Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice
by: Yanhong Wang, et al.
Published: (2022-03-01)

Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease
by: Sara Ahmed, et al.
Published: (2022-06-01)

N-linoleyltyrosine exerts neuroprotective effects in APP/PS1 transgenic mice via cannabinoid receptor-mediated autophagy
by: Chun-mei Long, et al.
Published: (2021-12-01)

Effects of Qi-Fu-Yin on aging of APP/PS1 transgenic mice by regulating the intestinal microbiome
by: Qiu-yue Xiao, et al.
Published: (2023-01-01)

Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017: part 3 – spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers
by: Albert Stuart Reece, et al.
Published: (2022-03-01)